VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
MMSI
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
MMSIMerit Medical Systems, Inc.
$72.14$4.3B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksMMSIQuarterly Financials

Merit Medical Systems, Inc. (MMSI) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Merit Medical Systems, Inc. (MMSI) quarterly income statement — complete revenue, gross profit & net income history

MMSI Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue381.88M394.18M384.26M381.95M354.33M355.16M339.85M338M323.51M323.29M315.23M320.06M297.56M293.42M287.18M294.98M275.42M278.49M267.02M280.32M
Revenue Growth %7.77%10.99%13.07%13%9.53%9.86%7.81%5.61%8.72%10.18%9.77%8.5%8.04%5.36%7.55%5.23%10.65%7.94%9.45%28.37%
Cost of Goods Sold197.08M198.74M197.75M197.73M182.8M182.18M182.31M176.9M171.79M188.09M173.03M167.27M159.2M158.86M158.6M159.91M154.51M149.69M146.53M156.19M
COGS % of Revenue51.61%50.42%51.46%51.77%51.59%51.29%53.64%52.34%53.1%58.18%54.89%52.26%53.5%54.14%55.23%54.21%56.1%53.75%54.87%55.72%
Gross Profit184.8M195.45M186.52M184.22M171.53M172.98M157.53M161.1M151.72M135.19M142.2M152.78M138.36M134.55M128.57M135.07M120.91M128.81M120.49M124.14M
Gross Margin %48.39%49.58%48.54%48.23%48.41%48.71%46.36%47.66%46.9%41.82%45.11%47.74%46.5%45.86%44.77%45.79%43.9%46.25%45.13%44.28%
Gross Profit Growth %7.73%12.99%18.4%14.35%13.06%27.95%10.78%5.44%9.65%0.48%10.6%13.12%14.44%4.46%6.7%8.8%8.05%15.87%18.12%47.41%
Operating Expenses140.82M141.37M143.77M137.46M120.76M136.42M120.27M115.15M115.91M102.44M107.06M123.97M111.98M104.14M109.92M111.81M105.67M106.91M104.56M115.24M
OpEx % of Revenue36.88%35.86%37.41%35.99%34.08%38.41%35.39%34.07%35.83%31.69%33.96%38.73%37.63%35.49%38.27%37.91%38.37%38.39%39.16%41.11%
Selling, General & Admin118.21M114.83M119.8M113.1M98.29M107.97M99.64M94.58M94.43M80.81M86.85M100.93M90.14M83.24M89.78M85.49M84.02M76.63M86.47M91.56M
SG&A % of Revenue30.95%29.13%31.18%29.61%27.74%30.4%29.32%27.98%29.19%25%27.55%31.53%30.29%28.37%31.26%28.98%30.5%27.52%32.38%32.66%
Research & Development22.61M26.54M23.97M24.37M22.48M25.19M20.53M20.26M21.48M21.64M19.65M20.13M21.31M20.44M19.22M18.47M17.39M20.41M16.97M17.59M
R&D % of Revenue5.92%6.73%6.24%6.38%6.34%7.09%6.04%5.99%6.64%6.69%6.23%6.29%7.16%6.96%6.69%6.26%6.31%7.33%6.36%6.28%
Other Operating Expenses000001000K103K306K00562K1000K521K456K915K1000K1000K1000K1000K1000K
Operating Income44.16M54.08M42.75M46.76M50.77M36.56M37.26M45.95M35.92M32.75M35.14M28.81M26.38M30.42M18.66M23.26M15.23M21.9M15.93M8.89M
Operating Margin %11.56%13.72%11.13%12.24%14.33%10.3%10.96%13.59%11.1%10.13%11.15%9%8.87%10.37%6.5%7.88%5.53%7.86%5.97%3.17%
Operating Income Growth %-13.02%47.9%14.73%1.76%41.33%11.65%6.04%59.47%36.16%7.67%88.33%23.89%73.2%38.92%17.11%161.45%7.32%36.79%24792.19%146.83%
EBITDA44.16M88.41M76.99M80.56M83.04M68.16M66.64M72.98M62.64M59.06M61.87M53.86M49.58M53.48M41.77M46.23M38.28M45.57M39.55M32.92M
EBITDA Margin %11.56%22.43%20.04%21.09%23.44%19.19%19.61%21.59%19.36%18.27%19.63%16.83%16.66%18.23%14.54%15.67%13.9%16.36%14.81%11.74%
EBITDA Growth %-46.83%29.7%15.53%10.39%32.57%15.4%7.72%35.49%26.34%10.43%48.13%16.52%29.51%17.38%5.59%40.45%-0.99%6.36%48.34%315.08%
D&A (Non-Cash Add-back)034.33M34.24M33.8M32.28M31.6M29.38M27.03M26.72M26.31M26.73M25.05M23.2M23.07M23.11M22.97M23.05M23.67M23.62M24.02M
EBIT054.08M42.75M46.76M50.77M41.14M44.16M53.52M42.39M37.14M35.06M28.58M27.51M32.31M19.43M22.05M15.17M21.29M15.41M8.25M
Net Interest Income0-2.46M-3.14M-3.01M-2.78M-3.25M-849K-118K-770K-3.05M-4.66M-3.46M-1.88M-2.04M-1.72M-1.25M-898K-1M-1.13M-1.29M
Interest Income3.9M3.9M3.62M3.76M3.79M4.74M6.65M7.56M7.28M1.92M181K221K131K123K116K96K104K101K104K92K
Interest Expense-6.53M6.36M6.75M6.78M6.57M7.99M7.5M7.68M8.05M4.98M4.84M3.68M2.01M2.16M1.83M1.35M1M1.1M1.23M1.39M
Other Income/Expense9.39M-3.02M-4.21M-3.38M-12.81M-3.42M-604K-103K-1.57M-1.28M-4.92M-3.91M-883K-262K-1.05M-2.56M-1.06M-1.72M-1.75M-2.03M
Pretax Income53.55M51.06M38.54M43.38M37.96M33.15M36.66M45.84M34.35M31.47M30.22M24.9M25.5M30.16M17.6M20.7M14.17M20.18M14.18M6.87M
Pretax Margin %14.02%12.95%10.03%11.36%10.71%9.33%10.79%13.56%10.62%9.73%9.59%7.78%8.57%10.28%6.13%7.02%5.15%7.25%5.31%2.45%
Income Tax12.55M13.05M10.79M10.8M7.81M5.2M8.21M10.12M6.11M3.84M4.39M4.66M4.8M-3.25M2.33M5.4M3.63M-432K2.21M1.95M
Effective Tax Rate %23.44%25.57%27.98%24.89%20.58%15.68%22.4%22.07%17.78%12.2%14.52%18.69%18.81%-10.76%13.24%26.1%25.59%-2.14%15.59%28.39%
Net Income40.99M38.01M27.75M32.58M30.15M27.95M28.44M35.73M28.24M27.63M25.83M20.25M20.7M33.4M15.27M15.3M10.54M20.61M11.97M4.92M
Net Margin %10.74%9.64%7.22%8.53%8.51%7.87%8.37%10.57%8.73%8.55%8.2%6.33%6.96%11.38%5.32%5.19%3.83%7.4%4.48%1.75%
Net Income Growth %35.98%35.99%-2.42%-8.8%6.75%1.15%10.1%76.47%36.41%-17.28%69.16%32.34%96.33%62.04%27.62%211.19%-3.77%34.04%497.71%125.79%
Net Income (Continuing)40.99M38.01M27.75M32.58M30.15M27.95M28.44M35.73M28.24M27.63M25.83M20.25M20.7M33.4M15.27M15.3M10.54M20.61M11.97M4.92M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)0.680.630.460.540.490.460.480.610.480.470.440.350.360.580.270.270.180.360.210.09
EPS Growth %38.78%36.96%-4.17%-11.48%2.08%-2.13%9.09%74.29%33.33%-18.97%62.96%29.63%100%61.11%28.57%200%-5.26%33.33%487.45%126.47%
EPS (Basic)0.690.640.470.550.510.480.490.610.490.480.450.350.360.590.270.270.190.360.210.09
Diluted Shares Outstanding60.01M60.03M59.92M60.61M61.28M60.61M59.54M58.74M58.57M58.38M58.38M58.47M58.18M57.96M57.59M57.6M57.53M57.62M57.55M57.28M
Basic Shares Outstanding59.51M59.34M59.24M59.14M58.9M58.54M58.23M58.14M57.96M57.79M57.68M57.54M57.35M57.1M56.84M56.69M56.59M56.49M56.3M56.06M
Dividend Payout Ratio--------------------